DNA RNA and Cells

07 Feb 2018 Akcea Completes Enrollment in Phase 2b Study of AKCEA-APO(a)-LRx
07 Feb 2018 Audentes Therapeutics Announces Selection of Optimized Clinical Development Candidate for Pompe Disease Program
07 Feb 2018 Sangamo Therapeutics Presents Initial Safety Data from CHAMPIONS Genome Editing Study for MPS II at WORLDSymposium
06 Feb 2018 Fibrocell Announces Submission of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized Scleroderma
04 Feb 2018 miRagen Therapeutics Presents New Data from Phase 1 Clinical Trial of MRG-106 in Mycosis Fungoides at the T-Cell Lymphoma Forum
02 Feb 2018 Alnylam Announces FDA Acceptance of New Drug Application (NDA) and Priority Review Status for Patisiran, an Investigational RNAi Therapeutic for the Treatment of Hereditary ATTR (hATTR) Amyloidosis
01 Feb 2018 Novartis announces NEJM publication of updated analysis from ELIANA trial showing longer-term durable remissions with Kymriah(TM) in children, young adults with r/r ALL
31 Jan 2018 Bellicum Pharmaceuticals Announces Clinical Hold on BPX-501 Clinical Trials in the United States
29 Jan 2018 SillaJen Announces First Patient Enrolled in the NCI-Sponsored Trial Evaluating Combination Therapy in Colorectal Cancer with SillaJen's Pexa-Vec Oncolytic Immunotherapy
26 Jan 2018 Alnylam Announces EMA Acceptance of Marketing Authorisation Application (MAA) for Patisiran for the Treatment of Hereditary ATTR (hATTR) Amyloidosis
25 Jan 2018 Rexgenero Treats First Patient in its Phase III Programme with Lead Product REX-001, a Novel Cell Therapy for the Treatment of Critical Limb Ischemia (CLI)
25 Jan 2018 American Gene Technologies Announces Progress toward Phase I Clinical Trial of AGT103-T for HIV Functional Cure
25 Jan 2018 Iovance Biotherapeutics Announces Preliminary Phase 2 Data for TIL Treatment in Head and Neck and Cervical Cancers
24 Jan 2018 Voyager Therapeutics Announces FDA Clearance of Investigational New Drug Application for VY-AADC for Advanced Parkinson’s Disease
23 Jan 2018 AnGes Submits Application for Marketing Approval to PMDA for HGF gene therapy for Critical Limb Ischemia
22 Jan 2018 Agenus Announces Combination Clinical Trials of its Anti-CTLA4 (AGEN1884) & Anti-PD1 (AGEN2034)
22 Jan 2018 Encouraging Early Safety and Efficacy Data in Cynata’s Phase 1 Trial of CYP-001 in GvHD; DSMB Recommendation to Initiate Enrolment of Second Patient Cohort
22 Jan 2018 Enrollment Completed in Randomized Clinical Trial of Habeo™ Cell Therapy for Scleroderma and Impaired Hand Function
18 Jan 2018 Kite Announces Clinical Collaboration to Evaluate Investigational Combination of Yescarta™ (Axicabtagene Ciloleucel) and Pfizer’s Utomilumab in Large B-Cell Lymphoma
18 Jan 2018 Caladrius Biosciences Announces Completion of Enrollment of Phase 2 T-Rex Clinical Trial of CLBS03 for Type 1 Diabetes
17 Jan 2018 Novartis granted US FDA Priority Review for Kymriah(TM) (tisagenlecleucel), formerly CTL019, for adults with r/r DLBCL
16 Jan 2018 Gamida Cell Announces Initiation of a Phase I Study of NAM-NK Cells Immunotherapy
16 Jan 2018 Ophthotech Announces First Patient Enrolled in the Phase 2b Clinical Trial of Zimura®, Complement C5 Inhibitor, for the Treatment of Autosomal Recessive Stargardt Disease (STGD1)
16 Jan 2018 AveXis Announces Expanded Clinical Development Program for AVXS-101 in Spinal Muscular Atrophy
11 Jan 2018 Forty Seven Inc. to Collaborate with Merck KGaA, Darmstadt, Germany, on a Novel Immuno-Oncology Combination for Ovarian Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up